Tolnaftate

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tolnaftate
Generic name: TOLNAFTATE
Manufacturer: Sheffield Pharmaceuticals LLC
Product type: HUMAN OTC DRUG
SPL set ID: ca52af37-c3a2-414c-a24a-a37a92925133
SPL ID: b4271182-7791-423e-8335-dfd5cb5d859b
Version: 5
Effective date: 2025-02-20
Source export date: 2026-10-30
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/8d15bdc5962e7531569eaeb5b1b2e4919574d40a6782ab67345a27b890175a00/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:57:11

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 13 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Tolnaftate	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		Sheffield Pharmaceuticals LLC	openfda.manufacturer_name
ndc	package	11527-051-40	openfda.package_ndc
ndc	package	11527-051-51	openfda.package_ndc
ndc	product	11527-051	openfda.product_ndc
ndc11	package	11527005140	derived:openfda.package_ndc
ndc11	package	11527005151	derived:openfda.package_ndc
rxcui		103951	openfda.rxcui
spl id		b4271182-7791-423e-8335-dfd5cb5d859b	id
spl set id		ca52af37-c3a2-414c-a24a-a37a92925133	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use on children under 2 years of age unless directed by a doctor. For external use only avoid contact with eyes. Irritation occurs or if there is no improvement within 4 weeks (for athlete's foot and ringworm)irritation occurs or if there is no improvement within 2 weeks (for jock itch).

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.